Danoprevir is a highly potent, orally absorbed inhibitor of the NS3/4A protease for treating chronic HCV infections. This agent is currently in Phase 2b study.

June 21, 2017

prudect name : Danoprevir is a highly potent, orally absorbed inhibitor of the NS3/4A protease for treating chronic HCV infections. This agent is currently in Phase 2b study.
Danoprevir

Synonyms: ITMN-191CAS NO: 850876-88-9Molecular Formula: C₃₅H₄₈FN₅O₈SMolecular Weight: 717.85Purity: 98% minSolubility: In DMSOStorage: −20°C

ZM-241385 References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18509787